PHARMACIE GRANDJEAN : revenue, balance sheet and financial ratios

PHARMACIE GRANDJEAN is a French company founded 37 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-AMOUR (39160), this company of category PME shows in 2016 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE GRANDJEAN (SIREN 350714168)
Indicator 2018 2017 2016 2015
Revenue N/C N/C 1 255 864 € 1 567 437 €
Net income 80 097 € 56 243 € 50 048 € 72 911 €
EBITDA N/C N/C 11 222 € 47 543 €
Net margin N/C N/C 4.0% 4.7%

Revenue and income statement

In 2018, PHARMACIE GRANDJEAN generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2018: 73 k€ -> 80 k€.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

80 097 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 287%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

286.504%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

25.363%

Solvency indicators evolution
PHARMACIE GRANDJEAN

Sector positioning

Debt ratio
286.5 2018
2016
2017
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Average

In 2018, the debt ratio of PHARMACIE GRANDJEAN (286.50) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
25.36% 2018
2016
2017
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Average +6 pts over 3 years

In 2018, the financial autonomy of PHARMACIE GRANDJEAN (25.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
13.65 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Average

In 2016, the repayment capacity of PHARMACIE GRANDJEAN (13.65) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 5073.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

5073.862

Liquidity indicators evolution
PHARMACIE GRANDJEAN

Sector positioning

Liquidity ratio
5073.86 2018
2016
2017
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Excellent

In 2018, the liquidity ratio of PHARMACIE GRANDJEAN (5073.86) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.02x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Average

In 2016, the interest coverage of PHARMACIE GRANDJEAN (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE GRANDJEAN

Positioning of PHARMACIE GRANDJEAN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 177 transactions of similar company sales in 2018, the value of PHARMACIE GRANDJEAN is estimated at 1 008 492 € (range 751 640€ - 1 658 735€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2018
177 transactions
751k€ 1008k€ 1658k€
1 008 492 € Range: 751 640€ - 1 658 735€
NAF 5 année 2018

Valuation method used

Net Income Multiple
80 097 € × 12.6x = 1 008 493 €
Range: 751 641€ - 1 658 735€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE GRANDJEAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE GRANDJEAN

What is the revenue of PHARMACIE GRANDJEAN ?

The revenue of PHARMACIE GRANDJEAN in 2016 is 1.3 M€.

Is PHARMACIE GRANDJEAN profitable?

Yes, PHARMACIE GRANDJEAN generated a net profit of 80 k€ in 2018.

Where is the headquarters of PHARMACIE GRANDJEAN ?

The headquarters of PHARMACIE GRANDJEAN is located in SAINT-AMOUR (39160), in the department Jura.

Where to find the tax return of PHARMACIE GRANDJEAN ?

The tax return of PHARMACIE GRANDJEAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE GRANDJEAN operate?

PHARMACIE GRANDJEAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.